Amgen Inc. cancer drug, Lumakras, is displayed in its packaging at Thousand Oaks, in California, United States September 10, 2022. Amgen/Handout via REUTERS
Amgen Inc. cancer drug, Lumakras, is displayed in its packaging at Thousand Oaks, in California, United States September 10, 2022. Amgen/Handout via REUTERS